Tissue distribution and ontogeny of organic cation transporters in mice

Yazen Alnouti, Jay S. Petrick, Curtis D. Klaassen

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Organic cation transporters (Octs) play an important role in transporting cationic xeno- and endobiotics across biological membranes. Little is known about Octs in mice; therefore, the tissue distribution and developmental changes in the mRNA expression of Octs in mice were quantified. Oct1, Oct2, Oct3, Octn1, Octn2, and Octn3 mRNA expression was quantified in 14 tissues from male and female mice using the branched DNA signal amplification assay. Oct1 mRNA expression was highest in kidney, followed by liver. Oct2 mRNA was almost exclusively expressed in kidney, with male mice having twice that in female mice. The higher expression of Oct2 in male mice is due to testosterone. Oct3 mRNA was most highly expressed in placenta, ovary, and uterus, but was expressed at low levels in most tissues. Octn1 and Octn2 mRNA expression was similar, with the highest levels in kidney followed by small intestine. Octn3 mRNA was almost exclusively expressed in testes. The developmental expression of Oct1, Oct2, Octn1, and Octn2 mRNA in kidneys as well as Oct1 in liver was determined in young mice. Ontogenic expression data indicate that each of the Octs approached adult expression levels by about 3 weeks of age. The gender difference in Oct mRNA expression did not become apparent until day 30 after birth. The differences in tissue distribution of the Octs may play an important role in drug disposition to various tissues. Furthermore, low expression of the Octs in young animals may affect the pharmacokinetic behavior of drugs compared with that in adults.

Original languageEnglish (US)
Pages (from-to)477-482
Number of pages6
JournalDrug Metabolism and Disposition
Volume34
Issue number3
DOIs
StatePublished - Mar 1 2006

Fingerprint

Tissue Distribution
Cations
Tissue
Messenger RNA
Kidney
Liver
Branched DNA Signal Amplification Assay
Biological membranes
Pharmacokinetics
Xenobiotics
Pharmaceutical Preparations
Placenta
Small Intestine
Uterus
Amplification
Testosterone
Testis
Ovary
Assays
Animals

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Tissue distribution and ontogeny of organic cation transporters in mice. / Alnouti, Yazen; Petrick, Jay S.; Klaassen, Curtis D.

In: Drug Metabolism and Disposition, Vol. 34, No. 3, 01.03.2006, p. 477-482.

Research output: Contribution to journalArticle

Alnouti, Yazen ; Petrick, Jay S. ; Klaassen, Curtis D. / Tissue distribution and ontogeny of organic cation transporters in mice. In: Drug Metabolism and Disposition. 2006 ; Vol. 34, No. 3. pp. 477-482.
@article{c491551ecbd24b9b843054fdf34a4f22,
title = "Tissue distribution and ontogeny of organic cation transporters in mice",
abstract = "Organic cation transporters (Octs) play an important role in transporting cationic xeno- and endobiotics across biological membranes. Little is known about Octs in mice; therefore, the tissue distribution and developmental changes in the mRNA expression of Octs in mice were quantified. Oct1, Oct2, Oct3, Octn1, Octn2, and Octn3 mRNA expression was quantified in 14 tissues from male and female mice using the branched DNA signal amplification assay. Oct1 mRNA expression was highest in kidney, followed by liver. Oct2 mRNA was almost exclusively expressed in kidney, with male mice having twice that in female mice. The higher expression of Oct2 in male mice is due to testosterone. Oct3 mRNA was most highly expressed in placenta, ovary, and uterus, but was expressed at low levels in most tissues. Octn1 and Octn2 mRNA expression was similar, with the highest levels in kidney followed by small intestine. Octn3 mRNA was almost exclusively expressed in testes. The developmental expression of Oct1, Oct2, Octn1, and Octn2 mRNA in kidneys as well as Oct1 in liver was determined in young mice. Ontogenic expression data indicate that each of the Octs approached adult expression levels by about 3 weeks of age. The gender difference in Oct mRNA expression did not become apparent until day 30 after birth. The differences in tissue distribution of the Octs may play an important role in drug disposition to various tissues. Furthermore, low expression of the Octs in young animals may affect the pharmacokinetic behavior of drugs compared with that in adults.",
author = "Yazen Alnouti and Petrick, {Jay S.} and Klaassen, {Curtis D.}",
year = "2006",
month = "3",
day = "1",
doi = "10.1124/dmd.105.006932",
language = "English (US)",
volume = "34",
pages = "477--482",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Tissue distribution and ontogeny of organic cation transporters in mice

AU - Alnouti, Yazen

AU - Petrick, Jay S.

AU - Klaassen, Curtis D.

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Organic cation transporters (Octs) play an important role in transporting cationic xeno- and endobiotics across biological membranes. Little is known about Octs in mice; therefore, the tissue distribution and developmental changes in the mRNA expression of Octs in mice were quantified. Oct1, Oct2, Oct3, Octn1, Octn2, and Octn3 mRNA expression was quantified in 14 tissues from male and female mice using the branched DNA signal amplification assay. Oct1 mRNA expression was highest in kidney, followed by liver. Oct2 mRNA was almost exclusively expressed in kidney, with male mice having twice that in female mice. The higher expression of Oct2 in male mice is due to testosterone. Oct3 mRNA was most highly expressed in placenta, ovary, and uterus, but was expressed at low levels in most tissues. Octn1 and Octn2 mRNA expression was similar, with the highest levels in kidney followed by small intestine. Octn3 mRNA was almost exclusively expressed in testes. The developmental expression of Oct1, Oct2, Octn1, and Octn2 mRNA in kidneys as well as Oct1 in liver was determined in young mice. Ontogenic expression data indicate that each of the Octs approached adult expression levels by about 3 weeks of age. The gender difference in Oct mRNA expression did not become apparent until day 30 after birth. The differences in tissue distribution of the Octs may play an important role in drug disposition to various tissues. Furthermore, low expression of the Octs in young animals may affect the pharmacokinetic behavior of drugs compared with that in adults.

AB - Organic cation transporters (Octs) play an important role in transporting cationic xeno- and endobiotics across biological membranes. Little is known about Octs in mice; therefore, the tissue distribution and developmental changes in the mRNA expression of Octs in mice were quantified. Oct1, Oct2, Oct3, Octn1, Octn2, and Octn3 mRNA expression was quantified in 14 tissues from male and female mice using the branched DNA signal amplification assay. Oct1 mRNA expression was highest in kidney, followed by liver. Oct2 mRNA was almost exclusively expressed in kidney, with male mice having twice that in female mice. The higher expression of Oct2 in male mice is due to testosterone. Oct3 mRNA was most highly expressed in placenta, ovary, and uterus, but was expressed at low levels in most tissues. Octn1 and Octn2 mRNA expression was similar, with the highest levels in kidney followed by small intestine. Octn3 mRNA was almost exclusively expressed in testes. The developmental expression of Oct1, Oct2, Octn1, and Octn2 mRNA in kidneys as well as Oct1 in liver was determined in young mice. Ontogenic expression data indicate that each of the Octs approached adult expression levels by about 3 weeks of age. The gender difference in Oct mRNA expression did not become apparent until day 30 after birth. The differences in tissue distribution of the Octs may play an important role in drug disposition to various tissues. Furthermore, low expression of the Octs in young animals may affect the pharmacokinetic behavior of drugs compared with that in adults.

UR - http://www.scopus.com/inward/record.url?scp=33344454764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33344454764&partnerID=8YFLogxK

U2 - 10.1124/dmd.105.006932

DO - 10.1124/dmd.105.006932

M3 - Article

C2 - 16381671

AN - SCOPUS:33344454764

VL - 34

SP - 477

EP - 482

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 3

ER -